Ally Bridge Group
  • About
  • Strategies
  • Team
  • Investments
  • News
  • Contact
  • Investor Login
    • Private Equity
      • Citco One
      • State Street Global Services
    • Public Equity

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Appointment reinforces ProMIS Neurosciences’ strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer’s program, PMN310 CAMBRIDGE, MA—(GLOBE NEWSWIRE)—ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company…

SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy

VALENCIA, CA—SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, announced that it has raised $140 million in private financing, that includes $25 million…

Private Equity Portfolio News: Epicrispr Biotechnologies Secures $68 Million Series B to Initiate Clinical Trial for First-in-Class Disease-Modifying Epigenetic Neuromuscular Therapy for FSHD

Financing led by Ally Bridge Group, with participation from SOLVE FSHD, a venture philanthropy organization Lead program, EPI-321, is the first clinical application of epigenetic modulation in neuromuscular diseases, with…

Private Equity Portfolio News: Cardiac Dimensions Raises $53 Million Series E Financing

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System KIRKLAND, WA—Cardiac Dimensions®, a leader in minimally invasive treatments for…

Private Equity Portfolio News: VitalConnect, Inc. Secures $100 Million in Financing

Latest Funding Accelerates the Company’s Commercial Expansion SAN JOSE, CA—VitalConnect®, Inc., a leader in biosensor technology, specializing in ambulatory cardiac monitoring, today announced the closing of $100 million in financing…

Private Equity Portfolio News: Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC Aadi Enters Agreement to Sell FYARRO® and Associated Infrastructure to KAKEN…

Late-Stage Investors Seek to Bring Medtech Startups to the Home Stretch

Medical-device companies are raising big venture rounds to fortify their business and position themselves for a strong public offering or sale Venture investors are writing large checks to maturing medical-device…

Private Equity Portfolio News: Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors

Financing Fuels the Company’s Hypergrowth to Make Elevated Care Accessible to More Patients. Petrovic’s Appointment Positions Imperative Care for Long Term Success and Scale. CAMPBELL, CA—(BUSINESS WIRE)—Imperative Care, Inc., a…

Private Equity Portfolio News: Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

Kestra Medical Technologies, Inc. announced today an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with its…

Private Equity Portfolio News: Insightec Announces $150M Financing to Fund Continued Growth

Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead Robust Investor Syndicate. FOR IMMEDIATE RELEASE: HAIFA, ISRAEL AND MIAMI, FL—Insightec, a global healthcare company…

Posts navigation

1 2 … 8
9
November